Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies

Human Gene Therapy

Volumn 8, Issue 11, 1997, Pages 1395-1401

  Haack, K ^a   Moebius, U ^b   Knebel Doeberitz, M V ^a   Herfarth, Ch ^a   Schackert, H K ^a,c   Gebert, J F ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; CYTOSINE DEAMINASE; DRUG METABOLIZING ENZYME; FLUCYTOSINE; FLUOROURACIL; HYBRID PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; FLOW CYTOMETRY; GENE TRANSFER; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN EXPRESSION; RAT; SUICIDE GENE; TUMOR CELL;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030845883     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.11-1395     Document Type: Article

References (30)

1. AUSTIN, E.A., and HUBER, B.E. (1993). A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharmacol. 43, 380-387.
2. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K., eds. (1987). Current Protocols in Molecular Biology. (John Wiley and Sons, New York).
3. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. CONSALVO, M., MULLEN, C.A., MODESTI, A., MUSIANI, P., ALLIONE, A., CAVALLO, F., GIOVARELLI, M., and FORNI, G. (1995). 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J. Immunol. 154, 5302-5312.
5. DANIELSEN, S., KILSTRUP, M., BARILLA, K., JOCHIMSEN, B., and NEUHARD, J. (1992). Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase. Mol. Microbiol. 6, 1335-1344.
6. DEUSCHLE, U., PEPPERKOK, R., WANG, F., GIORDANO, T.J., McALLISTER, W.T., ANSORGE, W., and BUJARD, H. (1989). Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor. Proc. Natl. Acad. Sci. USA 86, 5400-5404.
7. DONG, Y., WEN, P., MANOME, Y., PARR, M., HIRSHOWITZ, A., CHEN, L., HIRSCHOWITZ, E.A., CRYSTAL, R., WEICHSELBAUM, R., KUFE, D.W., and FINE, H.A. (1996). In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther. 7, 713-720.
8. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
9. HARLOW, W.E., and LANE, D. (1988). Antibodies: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
10. HARRIS, J.D., GUTIERREZ, A.A., HURST, H.C., SIKORA, K., and LEMOINE, N.R. (1994). Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther. 1, 170-175.
11. HIRSCHOWITZ, E.A., OHWADA, A., PASCAL, W.R., RUSSI, T.J., and CRYSTAL, R.G. (1995). In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6, 1055-1063.
12. HOCHULI, E., BANNWARTH, W., DÖBELI, H., GENTZ, R., and STÜBER, D. (1988). Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology 6, 1321-1325.
13. HOGANSON, D.K., BATRA, R.K., OLSEN, J.C., and BOUCHER, R.C. (1996). Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res. 56, 1315-1323.
14. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
15. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., DAVIS, S.T., and GOOD, S.S. (1994). Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA 91, 8302-8306.
16. KEARNEY, J.F., RADBRUCH, A., LIESEGANG, B., and RAJEWSKY, K. (1979). A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J. Immunol. 123, 1548-1550.
17. KERR, D.E., GARRIGUES, U.S., WALLACE, P.M., HELLSTRÖM, K.E., HELLSTRÖM, I., and SENTER, P.D. (1993). Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate. Bioconjugate Chem. 4, 353-357.
18. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
19. LYONS, R.H., FERGUSON, B.Q., and ROSENBERG, M. (1987). Pentapeptide nuclear localization signal in adenovirus E1a. Mol. Cell. Biol. 7, 2451-2456.
20. MATZKU, S., KOMITOWSKI, D., MILDENBERGER, M., and ZÖLLER, M. (1983). Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. Invasion Metastasis 3, 109-123.
21. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA 89, 33-37.
22. MULLEN, C.A., COALE, M.M., LOWE, R., and BLAESE, R.M. (1994). Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54, 1503-1506.
23. MULLEN, C.A., PETROPOULOS, D., and LOWE, R.M. (1996). Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes. Cancer Res. 56, 1361-1366.
24. ROWLEY, S., LINDAUER, M., GEBERT, J.F., HABERKORN, U., OBERDORFER, F., MOEBIUS, U., HERFARTH, C., and SCHACKERT, H.-K. (1996). Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer. J. Surgical Oncol. 61, 42-48.
25. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T., eds. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
26. lck and pp32, a possible common substrate. Eur. J. Immunol. 21, 2469-2477.
27. SENTER, P.D., SU, P.C.D., KATSURAGI, T., SAKAI, T., COSAND, W.L., HELLSTRÖM, I., and HELLSTRÖM, K.E. (1991). Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates. Bioconjugate Chem. 2, 447-451.
28. SILHAVY, T.J., BERMAN, M.L., and LYNN, W.E., eds. (1984). Experiments with Gene Fusions. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
29. TRINH, Q.T., AUSTIN, E.A., MURRAY, D.M., KNICK, V.C., and HUBER, B.E. (1995). Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res. 55, 4808-4812.
30. ZENTGRAF, H., FREY, M., SCHWINN, S., TESSMER, C., WILLEMANN, B., SAMSTAG, Y., and VELHAGEN, I. (1995). Detection of histidine-tagged fusion proteins by using a high-specific mouse monoclonal anti-histidine tag antibody. Nucleic Acids Res. 23, 3347-3348.